These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 29940415)
41. Codon-optimized filovirus DNA vaccines delivered by intramuscular electroporation protect cynomolgus macaques from lethal Ebola and Marburg virus challenges. Grant-Klein RJ; Altamura LA; Badger CV; Bounds CE; Van Deusen NM; Kwilas SA; Vu HA; Warfield KL; Hooper JW; Hannaman D; Dupuy LC; Schmaljohn CS Hum Vaccin Immunother; 2015; 11(8):1991-2004. PubMed ID: 25996997 [TBL] [Abstract][Full Text] [Related]
42. Stat1-Deficient Mice Are Not an Appropriate Model for Efficacy Testing of Recombinant Vesicular Stomatitis Virus-Based Filovirus Vaccines. Marzi A; Kercher L; Marceau J; York A; Callsion J; Gardner DJ; Geisbert TW; Feldmann H J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S404-9. PubMed ID: 26022440 [TBL] [Abstract][Full Text] [Related]
43. Antibodies to the Glycoprotein GP2 Subunit Cross-React between Old and New World Arenaviruses. Amanat F; Duehr J; Oestereich L; Hastie KM; Ollmann Saphire E; Krammer F mSphere; 2018; 3(3):. PubMed ID: 29720525 [TBL] [Abstract][Full Text] [Related]
44. Filovirus proteins for antiviral drug discovery: A structure/function analysis of surface glycoproteins and virus entry. Martin B; Hoenen T; Canard B; Decroly E Antiviral Res; 2016 Nov; 135():1-14. PubMed ID: 27640102 [TBL] [Abstract][Full Text] [Related]
45. Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections. Swenson DL; Warfield KL; Negley DL; Schmaljohn A; Aman MJ; Bavari S Vaccine; 2005 Apr; 23(23):3033-42. PubMed ID: 15811650 [TBL] [Abstract][Full Text] [Related]
46. Mapping of Ebolavirus Neutralization by Monoclonal Antibodies in the ZMapp Cocktail Using Cryo-Electron Tomography and Studies of Cellular Entry. Tran EE; Nelson EA; Bonagiri P; Simmons JA; Shoemaker CJ; Schmaljohn CS; Kobinger GP; Zeitlin L; Subramaniam S; White JM J Virol; 2016 Sep; 90(17):7618-27. PubMed ID: 27279622 [TBL] [Abstract][Full Text] [Related]
48. Post-exposure therapy of filovirus infections. Wong G; Qiu X; Olinger GG; Kobinger GP Trends Microbiol; 2014 Aug; 22(8):456-63. PubMed ID: 24794572 [TBL] [Abstract][Full Text] [Related]
49. Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies. Davidson E; Bryan C; Fong RH; Barnes T; Pfaff JM; Mabila M; Rucker JB; Doranz BJ J Virol; 2015 Nov; 89(21):10982-92. PubMed ID: 26311869 [TBL] [Abstract][Full Text] [Related]
50. Detection of anti-ebolavirus antibodies in Ghanaian pigs. Ogawa H; Ohya K; Ayizanga R; Miyamoto H; Shigeno A; Yamada M; Takashima Y; Inoue-Murayama M; Takada A; Baboreka Kayang B J Vet Med Sci; 2022 Nov; 84(11):1491-1494. PubMed ID: 36123040 [TBL] [Abstract][Full Text] [Related]
51. Integrated sequence and immunology filovirus database at Los Alamos. Yusim K; Yoon H; Foley B; Feng S; Macke J; Dimitrijevic M; Abfalterer W; Szinger J; Fischer W; Kuiken C; Korber B Database (Oxford); 2016; 2016():. PubMed ID: 27103629 [TBL] [Abstract][Full Text] [Related]
52. Development and Characterization of Neutralizing Antibodies Against Zaire Ebolavirus Glycoprotein and Protein 40. Yu DS; Weng TH; Shen L; Wu XX; Hu CY; Wang FXC; Wu ZG; Wu HB; Wu NP; Li LJ; Yao H Cell Physiol Biochem; 2018; 50(3):1055-1067. PubMed ID: 30355918 [TBL] [Abstract][Full Text] [Related]
53. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants. Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425 [TBL] [Abstract][Full Text] [Related]